Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trial

R. Motzer,E. Dmitrovsky,W. Miller,W. Tong,D. Bajorin,H. Scher,G. Bosl
DOI: https://doi.org/10.1002/1097-0142(19931201)72:11<3313::AID-CNCR2820721129>3.0.CO;2-C
IF: 6.9209
1993-12-01
Cancer
Abstract:Background. Several studies have indicated a role for specific growth factors in the differentiation or deregulated growth of germ cell cancers. One proposed mechanism of antitumor activity for suramin is the inhibition of these tumor‐derived growth factors.
What problem does this paper attempt to address?